TITLE

Technical Limitations of Sentinel Node Biopsy in Breast Cancer: A Single Surgeon's Experience

AUTHOR(S)
Patel, Nilesh A.; Dusi, Debra; Bragdon, Qwynne; Julian, Thomas B.
PUB. DATE
February 2003
SOURCE
American Surgeon;Feb2003, Vol. 69 Issue 2, p111
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Few studies have attempted to critically identify patient- and tumor-related factors that limit sentinel node biopsy (SNB). These studies have been limited by sample size and surgeon variability. The present study attempts to enumerate these limitations in a unique group of patients. One hundred twenty-five SNBs performed by a single surgeon between May 1997 and June 2001 were reviewed. Overall SNB was successful in 96 per cent of patients with a 97 per cent correlation with the axillary node dissection. Sentinel node identification was not affected by age, tumor size, tumor location, prior segmental resection, or neoadjuvant therapy. No false negatives were noted in the neoadjuvant group. The use of blue dye alone significantly understaged patients when compared with isotope alone (P = 0.02). SNB is a highly accurate method to identify axillary metastases and its limitations are not affected by patient or tumor related factors. In the present study SNB detection by both isotope and blue dye has been shown to be superior to blue dye alone. This finding demonstrates that these limitations may be overcome with the standardization of the technique used.
ACCESSION #
10544931

 

Related Articles

  • Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer. Muneaki Sano; Nobuaki Sato; Keiichi Homma // Surgery Today;Jul2008, Vol. 38 Issue 7, p585 

    Abstract Purpose  This study was undertaken to assess the feasibility of performing a sentinel lymph node biopsy (SLNB) for a patient with operable breast cancer after undergoing neoadjuvant chemotherapy (NAC). Method  Between January 2002 and December 2003, women with primary...

  • International Multicenter Tool to Predict the Risk of Nonsentinel Node Metastases in Breast Cancer. Meretoja, Tuomo J.; Leidenius, Marjut H. K.; Heikkilä, Päiivi S.; Boross, Gabor; Sejben, István; Regitnig, Peter; Luschin-Ebengreuth, Gero; Žgajnar, Janez; Perhavec, Andraz; Gazic, Barbara; Lázár, György; Takács, Tiber; Vörös, Andras; Saidan, Zuhair A.; Nadeem, Rana M.; Castellano, Isabella; Sapino, Anna; Bianchi, Simonetta; Vezzosi, Vania; Barranger, Emmanuel // JNCI: Journal of the National Cancer Institute;12/19/2012, Vol. 104 Issue 24, p1888 

    Background Axillary treatment of breast cancer patients is undergoing a paradigm shift, as completion axillary lymph node dissections (ALNDs) are being questioned in the treatment of patients with tumor-positive sentinel nodes. This study aims to develop a novel multi-institutional predictive...

  • You Be the Coder.  // General Surgery Coding Alert;Apr2010, Vol. 12 Issue 4, p27 

    The article offers information on the importance of separately coding the sentinel lymph node biopsy through appropriate coding.

  • Role of axillary lymph-node dissection in the management of breast cancer. Wexler, Marvin J. // Canadian Journal of Surgery;Aug2003, Vol. 46 Issue 4, p247 

    Discusses the role of axillary lymph-node dissection (ALND) in the management of early-stage breast cancer. Identification of patients who are at risk for recurrence; Incidence of axillary lymph node involvement at the time of diagnosis of breast cancer; Post-operative complications of ALND.

  • Gamma-probe-guided resection of the sentinel lymph node in breast cancer. Crossin, James A.; Johnson, A. Cedric; Stewart, Paul B.; Turner, William W. // American Surgeon;Jul1998, Vol. 64 Issue 7, p666 

    Studies the feasibility and sensitivity of sentinel lymph node excisions in patients with breast cancer. Identification of radiolabeled sentinel lymph nodes in breast cancer patients; Determination of axillary lymph node metastases in patients through radiolabeled sentinel lymph node biopsy;...

  • Correlation Between Clinical Nodal Status and Sentinel Lymph Node Biopsy False Negative Rate After Neoadjuvant Chemotherapy. Takahashi, Maiko; Jinno, Hiromitsu; Hayashida, Tetsu; Sakata, Michio; Asakura, Keiko; Kitagawa, Yuko // World Journal of Surgery;Dec2012, Vol. 36 Issue 12, p2847 

    Background: Neoadjuvant chemotherapy (NAC) is the standard treatment for locally advanced breast cancer. It is now being used to treat operable breast cancer to facilitate breast-conserving surgery, but the accuracy of sentinel lymph node biopsy (SLNB) in breast cancer patients receiving NAC...

  • Axillary lymph node dissection did not improve survival in sentinel-node positive breast cancer.  // Hem/Onc Today;7/10/2010, Vol. 10 Issue 13, p19 

    The article discusses the ACOSOG Z0011 trial which found that axillary lymph node dissection failed to improve survival of women with sentinel-node positive early breast cancer.

  • Current status of sentinel lymph node surgery for breast cancer. Krag, David; Krag, D // JNCI: Journal of the National Cancer Institute;02/17/99, Vol. 91 Issue 4, p302 

    Discusses some issues that need to be addressed in sentinel lymph node surgery for breast cancer. Comprehensive detection of sentinel node; Complete staging of lymph nodes; Intraoperative pathology; Method of tracer injection.

  • Axillary lymph node dissection failed to improve outcomes in T1 NO breast cancer.  // Hem/Onc Today;3/10/2014, Vol. 15 Issue 5, p8 

    The article discusses research being done on the axillary lymph node dissection done on patients with breast cancer, which references a study by R. Agesti in a 2013 issue of "Cancer."

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics